|
US11111543B2
(en)
|
2005-07-29 |
2021-09-07 |
Natera, Inc. |
System and method for cleaning noisy genetic data and determining chromosome copy number
|
|
US9424392B2
(en)
|
2005-11-26 |
2016-08-23 |
Natera, Inc. |
System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
|
|
US11111544B2
(en)
|
2005-07-29 |
2021-09-07 |
Natera, Inc. |
System and method for cleaning noisy genetic data and determining chromosome copy number
|
|
US12152275B2
(en)
|
2010-05-18 |
2024-11-26 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
US11332793B2
(en)
|
2010-05-18 |
2022-05-17 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US11408031B2
(en)
|
2010-05-18 |
2022-08-09 |
Natera, Inc. |
Methods for non-invasive prenatal paternity testing
|
|
US11332785B2
(en)
|
2010-05-18 |
2022-05-17 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
US11339429B2
(en)
|
2010-05-18 |
2022-05-24 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
EP2572003A4
(en)
|
2010-05-18 |
2016-01-13 |
Natera Inc |
METHOD FOR NONINVASIVE PRANATAL PLOIDIE ASSIGNMENT
|
|
US20190010543A1
(en)
|
2010-05-18 |
2019-01-10 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US11939634B2
(en)
|
2010-05-18 |
2024-03-26 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US10316362B2
(en)
|
2010-05-18 |
2019-06-11 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US11326208B2
(en)
|
2010-05-18 |
2022-05-10 |
Natera, Inc. |
Methods for nested PCR amplification of cell-free DNA
|
|
US9677118B2
(en)
|
2014-04-21 |
2017-06-13 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US11322224B2
(en)
|
2010-05-18 |
2022-05-03 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
US12221653B2
(en)
|
2010-05-18 |
2025-02-11 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
WO2012088456A2
(en)
|
2010-12-22 |
2012-06-28 |
Natera, Inc. |
Methods for non-invasive prenatal paternity testing
|
|
AU2011358564B9
(en)
|
2011-02-09 |
2017-07-13 |
Natera, Inc |
Methods for non-invasive prenatal ploidy calling
|
|
AU2013249012B2
(en)
|
2012-04-19 |
2019-03-28 |
The Medical College Of Wisconsin, Inc. |
Highly sensitive surveillance using detection of cell free DNA
|
|
US20140100126A1
(en)
|
2012-08-17 |
2014-04-10 |
Natera, Inc. |
Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
|
|
EP3957749A1
(en)
|
2014-04-21 |
2022-02-23 |
Natera, Inc. |
Detecting tumour specific mutations in biopsies with whole exome sequencing and in cell-free samples
|
|
US20180173845A1
(en)
|
2014-06-05 |
2018-06-21 |
Natera, Inc. |
Systems and Methods for Detection of Aneuploidy
|
|
US20180142296A1
(en)
*
|
2015-04-30 |
2018-05-24 |
Medical College Of Wisconsin, Inc. |
Multiplexed optimized mismatch amplification (moma)-real time pcr for assessing cell-free dna
|
|
WO2016183106A1
(en)
|
2015-05-11 |
2016-11-17 |
Natera, Inc. |
Methods and compositions for determining ploidy
|
|
WO2017181202A2
(en)
|
2016-04-15 |
2017-10-19 |
Natera, Inc. |
Methods for lung cancer detection
|
|
BR112018072196A2
(pt)
*
|
2016-04-29 |
2019-02-12 |
Medical College Wisconsin Inc |
amplificação de incompatibilidade otimizada multiplexadas (moma) - número do alvo
|
|
EP3449018A4
(en)
*
|
2016-04-29 |
2019-11-06 |
The Medical College of Wisconsin, Inc. |
REAL-TIME PCR WITH MULTIPLEXED OPTIMIZED MISMATCH AMPLIFICATION (MOMA) FOR THE EVALUATION OF FETAL WELL-BEING
|
|
JP2019518437A
(ja)
*
|
2016-04-29 |
2019-07-04 |
ザ メディカル カレッジ オブ ウィスコンシン インクＴｈｅ Ｍｅｄｉｃａｌ Ｃｏｌｌｅｇｅ Ｏｆ Ｗｉｓｃｏｎｓｉｎ， Ｉｎｃ． |
多重／最適化ミスマッチ増幅（ｍｏｍａ）−がんの評価のためのリアルタイムｐｃｒ
|
|
US11485996B2
(en)
|
2016-10-04 |
2022-11-01 |
Natera, Inc. |
Methods for characterizing copy number variation using proximity-litigation sequencing
|
|
CN110114477A
(zh)
*
|
2016-11-02 |
2019-08-09 |
威斯康星州立大学医学院 |
用于使用总的和特异性无细胞dna评估风险的方法
|
|
CA3042722A1
(en)
*
|
2016-11-02 |
2018-05-11 |
The Medical College Of Wisconsin, Inc. |
Methods for assessing risk using mismatch amplification and statistical methods
|
|
GB201618485D0
(en)
|
2016-11-02 |
2016-12-14 |
Ucl Business Plc |
Method of detecting tumour recurrence
|
|
US10011870B2
(en)
|
2016-12-07 |
2018-07-03 |
Natera, Inc. |
Compositions and methods for identifying nucleic acid molecules
|
|
AU2018288835A1
(en)
|
2017-06-20 |
2020-01-16 |
The Medical College Of Wisconsin, Inc. |
Assessing conditions in transplant subjects using donor-specific cell-free DNA
|
|
CA3067635A1
(en)
*
|
2017-06-20 |
2018-12-27 |
The Medical College Of Wisconsin, Inc. |
Transplant patient monitoring with cell-free dna
|
|
AU2018288832B2
(en)
|
2017-06-20 |
2025-03-06 |
The Medical College Of Wisconsin, Inc. |
Assessing transplant complication risk with total cell-free DNA
|
|
JP2020531050A
(ja)
*
|
2017-08-17 |
2020-11-05 |
ティーエーアイ ダイアグノスティックス インコーポレイテッドＴａｉ Ｄｉａｇｎｏｓｔｉｃｓ，Ｉｎｃ． |
ドナー遺伝子型なしでドナー無細胞ｄｎａを決定する方法
|
|
JP2021506342A
(ja)
|
2017-12-14 |
2021-02-22 |
ティーエーアイ ダイアグノスティックス インコーポレイテッドＴａｉ Ｄｉａｇｎｏｓｔｉｃｓ，Ｉｎｃ． |
移植のための移植片適合性の評価
|
|
SG11202005474RA
(en)
*
|
2017-12-15 |
2020-07-29 |
Acrannolife Genomics Pvt Ltd |
A non-invasive method for monitoring transplanted organ status in organ-transplant recipients
|
|
CA3090426A1
(en)
|
2018-04-14 |
2019-10-17 |
Natera, Inc. |
Methods for cancer detection and monitoring by means of personalized detection of circulating tumor dna
|
|
US12234509B2
(en)
|
2018-07-03 |
2025-02-25 |
Natera, Inc. |
Methods for detection of donor-derived cell-free DNA
|
|
EP3899033A4
(en)
*
|
2018-12-17 |
2022-10-19 |
The Medical College of Wisconsin, Inc. |
Assessing risk with total cell-free dna
|
|
WO2020206290A1
(en)
*
|
2019-04-03 |
2020-10-08 |
The Medical College Of Wisconsin, Inc. |
Methods for assessing risk using total cell-free dna
|
|
US11931674B2
(en)
|
2019-04-04 |
2024-03-19 |
Natera, Inc. |
Materials and methods for processing blood samples
|
|
EP3980559A1
(en)
|
2019-06-06 |
2022-04-13 |
Natera, Inc. |
Methods for detecting immune cell dna and monitoring immune system
|
|
WO2021236962A1
(en)
|
2020-05-20 |
2021-11-25 |
The Medical College Of Wisconsin, Inc. |
Compositions and methods for inhibiting cytokine-release syndrome
|